218 related articles for article (PubMed ID: 9634050)
1. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial.
Clark LC; Dalkin B; Krongrad A; Combs GF; Turnbull BW; Slate EH; Witherington R; Herlong JH; Janosko E; Carpenter D; Borosso C; Falk S; Rounder J
Br J Urol; 1998 May; 81(5):730-4. PubMed ID: 9634050
[TBL] [Abstract][Full Text] [Related]
2. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.
Clark LC; Combs GF; Turnbull BW; Slate EH; Chalker DK; Chow J; Davis LS; Glover RA; Graham GF; Gross EG; Krongrad A; Lesher JL; Park HK; Sanders BB; Smith CL; Taylor JR
JAMA; 1996 Dec; 276(24):1957-63. PubMed ID: 8971064
[TBL] [Abstract][Full Text] [Related]
3. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial.
Duffield-Lillico AJ; Slate EH; Reid ME; Turnbull BW; Wilkins PA; Combs GF; Park HK; Gross EG; Graham GF; Stratton MS; Marshall JR; Clark LC;
J Natl Cancer Inst; 2003 Oct; 95(19):1477-81. PubMed ID: 14519754
[TBL] [Abstract][Full Text] [Related]
4. Reduction of cancer risk with an oral supplement of selenium.
Combs GF; Clark LC; Turnbull BW
Biomed Environ Sci; 1997 Sep; 10(2-3):227-34. PubMed ID: 9315315
[TBL] [Abstract][Full Text] [Related]
5. Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia.
Clark LC; Marshall JR
Urology; 2001 Apr; 57(4 Suppl 1):185-7. PubMed ID: 11295623
[TBL] [Abstract][Full Text] [Related]
6. Reduction of cancer mortality and incidence by selenium supplementation.
Combs GF; Clark LC; Turnbull BW
Med Klin (Munich); 1997 Sep; 92 Suppl 3():42-5. PubMed ID: 9342915
[TBL] [Abstract][Full Text] [Related]
7. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial.
Duffield-Lillico AJ; Dalkin BL; Reid ME; Turnbull BW; Slate EH; Jacobs ET; Marshall JR; Clark LC;
BJU Int; 2003 May; 91(7):608-12. PubMed ID: 12699469
[TBL] [Abstract][Full Text] [Related]
8. Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer.
Stratton MS; Algotar AM; Ranger-Moore J; Stratton SP; Slate EH; Hsu CH; Thompson PA; Clark LC; Ahmann FR
Cancer Prev Res (Phila); 2010 Aug; 3(8):1035-43. PubMed ID: 20647337
[TBL] [Abstract][Full Text] [Related]
9. Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.
Algotar AM; Stratton MS; Ahmann FR; Ranger-Moore J; Nagle RB; Thompson PA; Slate E; Hsu CH; Dalkin BL; Sindhwani P; Holmes MA; Tuckey JA; Graham DL; Parnes HL; Clark LC; Stratton SP
Prostate; 2013 Feb; 73(3):328-35. PubMed ID: 22887343
[TBL] [Abstract][Full Text] [Related]
10. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial.
Duffield-Lillico AJ; Reid ME; Turnbull BW; Combs GF; Slate EH; Fischbach LA; Marshall JR; Clark LC
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):630-9. PubMed ID: 12101110
[TBL] [Abstract][Full Text] [Related]
11. Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial.
Goodman PJ; Tangen CM; Darke AK; Arnold KB; Hartline J; Yee M; Anderson K; Caban-Holt A; Christen WG; Cassano PA; Lance P; Klein EA; Crowley JJ; Minasian LM; Meyskens FL
Trials; 2016 Aug; 17():400. PubMed ID: 27519183
[TBL] [Abstract][Full Text] [Related]
12. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
[TBL] [Abstract][Full Text] [Related]
13. A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study.
Frieling UM; Schaumberg DA; Kupper TS; Muntwyler J; Hennekens CH
Arch Dermatol; 2000 Feb; 136(2):179-84. PubMed ID: 10677093
[TBL] [Abstract][Full Text] [Related]
14. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Lippman SM; Klein EA; Goodman PJ; Lucia MS; Thompson IM; Ford LG; Parnes HL; Minasian LM; Gaziano JM; Hartline JA; Parsons JK; Bearden JD; Crawford ED; Goodman GE; Claudio J; Winquist E; Cook ED; Karp DD; Walther P; Lieber MM; Kristal AR; Darke AK; Arnold KB; Ganz PA; Santella RM; Albanes D; Taylor PR; Probstfield JL; Jagpal TJ; Crowley JJ; Meyskens FL; Baker LH; Coltman CA
JAMA; 2009 Jan; 301(1):39-51. PubMed ID: 19066370
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: a meta-analysis of randomized controlled trials.
Jiang L; Yang KH; Tian JH; Guan QL; Yao N; Cao N; Mi DH; Wu J; Ma B; Yang SH
Nutr Cancer; 2010; 62(6):719-27. PubMed ID: 20661819
[TBL] [Abstract][Full Text] [Related]
16. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Klein EA; Thompson IM; Tangen CM; Crowley JJ; Lucia MS; Goodman PJ; Minasian LM; Ford LG; Parnes HL; Gaziano JM; Karp DD; Lieber MM; Walther PJ; Klotz L; Parsons JK; Chin JL; Darke AK; Lippman SM; Goodman GE; Meyskens FL; Baker LH
JAMA; 2011 Oct; 306(14):1549-56. PubMed ID: 21990298
[TBL] [Abstract][Full Text] [Related]
17. Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' Study.
Stratton MS; Reid ME; Schwartzberg G; Minter FE; Monroe BK; Alberts DS; Marshall JR; Ahmann FR
Anticancer Drugs; 2003 Sep; 14(8):595-600. PubMed ID: 14501381
[TBL] [Abstract][Full Text] [Related]
18. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial.
Green A; Williams G; Neale R; Hart V; Leslie D; Parsons P; Marks GC; Gaffney P; Battistutta D; Frost C; Lang C; Russell A
Lancet; 1999 Aug; 354(9180):723-9. PubMed ID: 10475183
[TBL] [Abstract][Full Text] [Related]
19. Moving a randomized clinical trial into an observational cohort.
Goodman PJ; Hartline JA; Tangen CM; Crowley JJ; Minasian LM; Klein EA; Cook ED; Darke AK; Arnold KB; Anderson K; Yee M; Meyskens FL; Baker LH
Clin Trials; 2013 Feb; 10(1):131-42. PubMed ID: 23064404
[TBL] [Abstract][Full Text] [Related]
20. Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study.
Stratton MS; Reid ME; Schwartzberg G; Minter FE; Monroe BK; Alberts DS; Marshall JR; Ahmann FR
Anticancer Drugs; 2003 Sep; 14(8):589-94. PubMed ID: 14501380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
